{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:14:00Z","timestamp":1787318040928,"version":"build-2736575974"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Ethanol lock therapy (ELT) has been shown to reduce the incidence of catheter-related blood stream infections (CRBSI) in intestinal failure (IF) patients. Dosing and frequency remains undefined. Scrutiny of pharmaceutical facilities by the Food and Drug Administration led to the voluntary shutdown of the sole supplier of ethanol, resulting in a nationwide shortage. To conserve supply, we reduced ELT frequency from a daily regimen. We examined the impact that reduction in ELT frequency had on CRBSI in pediatric IF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We retrospectively reviewed our parenteral nutrition\u2013dependent IF children. Primary outcome measure was CRBSI per 1000 catheter days after ELT frequency reduction. Data were compared (paired t test) to the same group over 1 year before ethanol shortage and to historical controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>During the shortage 13 outpatients received ELT. Eight met study criteria. Mean \u00b1 SD age was 9.1 \u00b1 7.8 years. Mean CRBSI rate per 1000 catheter days was 0.7 \u00b1 1.3 before ELT shortage. This increased to 6.2 \u00b1 2.5 after frequency reduction (P &amp;lt; .001). This CRBSI rate was similar to historical IF children not on ELT (8.0 \u00b1 5.4). Seven children developed CRBSI after frequency reduction, 6 requiring hospitalization, 2 to the ICU. Mean length of stay (15.5 days) averaged $104,783(\u00b1 111,034) in hospital charges. Organisms included Gram-negatives (6), methicillin-resistant Staphylococcus aureus (1), and Candida spp (1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>ELT frequency reduction resulted in complete failure in CRBSI prophylaxis. The nationwide shortage of this drug has been costly both financially and in patient morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2011-3894","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T21:01:54Z","timestamp":1349730114000},"page":"e1369-e1373","source":"Crossref","is-referenced-by-count":35,"title":["Drug Shortage\u2013Associated Increase in Catheter-Related Blood Stream Infection in Children"],"prefix":"10.1542","volume":"130","author":[{"given":"Matthew W.","family":"Ralls","sequence":"first","affiliation":[{"name":"Section of Pediatric Surgery, Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Alexander","family":"Blackwood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan A.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Section of Pediatric Surgery, Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Partipilo","sequence":"additional","affiliation":[{"name":"Children\u2019s Intestinal Rehabilitation Program\/HomeMed, The University of Michigan Medical School and the C. S. Mott Children's Hospital, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dimond","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Teitelbaum","sequence":"additional","affiliation":[{"name":"Section of Pediatric Surgery, Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"issue":"2","key":"2021120903100651200_B1","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1053\/j.gastro.2005.12.002","article-title":"Causes and management of intestinal failure in children.","volume":"130","author":"Goulet","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"2021120903100651200_B2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0950-3528(98)90012-4","article-title":"Home enteral and parenteral nutrition in children.","volume":"12","author":"Colomb","year":"1998","journal-title":"Baillieres Clin Gastroenterol"},{"issue":"2","key":"2021120903100651200_B3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/spsu.2001.22382","article-title":"Short bowel syndrome in infants and children: an overview.","volume":"10","author":"Sigalet","year":"2001","journal-title":"Semin Pediatr Surg"},{"issue":"3","key":"2021120903100651200_B4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-3449","article-title":"Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.","volume":"122","author":"Cole","year":"2008","journal-title":"Pediatrics"},{"key":"2021120903100651200_B5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yasu.2008.03.012","article-title":"Prevention of catheter-related bloodstream infections.","volume":"42","author":"Rodriguez-Paz","year":"2008","journal-title":"Adv Surg"},{"issue":"9","key":"2021120903100651200_B6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/81.9.1159","article-title":"The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.","volume":"81","author":"Maki","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2021120903100651200_B7"},{"issue":"4","key":"2021120903100651200_B8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0148607107031004302","article-title":"Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients.","volume":"31","author":"Opilla","year":"2007","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"2021120903100651200_B9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkn284","article-title":"A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients.","volume":"62","author":"Sanders","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2021120903100651200_B10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jpedsurg.2010.02.099","article-title":"Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure.","volume":"45","author":"Jones","year":"2010","journal-title":"J Pediatr Surg"},{"issue":"5","key":"2021120903100651200_B11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/msj.20213","article-title":"Usefulness of anti-infective lock solutions for catheter-related bloodstream infections.","volume":"77","author":"Kim","year":"2010","journal-title":"Mt Sinai J Med"},{"issue":"10","key":"2021120903100651200_B12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archpedi.160.10.1049","article-title":"Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients.","volume":"160","author":"Onland","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"2021120903100651200_B13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00365540701756953","article-title":"Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.","volume":"40","author":"Broom","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2021120903100651200_B14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ajic.2011.01.003","article-title":"Guidelines for the prevention of intravascular catheter-related infections.","volume":"39","author":"O\u2019Grady","year":"2011","journal-title":"Am J Infect Control"},{"issue":"6","key":"2021120903100651200_B15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2008.02.026","article-title":"Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome.","volume":"43","author":"Mouw","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"1","key":"2021120903100651200_B16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0148607110362758","article-title":"Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure.","volume":"35","author":"Cober","year":"2011","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2021120903100651200_B17","unstructured":"Luitpold Pharmacueticals, Inc. announces temporary suspension of distribution and manufacture of drug products. April 21, 2011. Available at: www.americanregent.com\/documents\/news\/PCNJw+rtNk8=.pdf. Accessed September 30, 2011"},{"key":"2021120903100651200_B18","unstructured":"American Regent, Inc. A Luitpold Pharmaceuticals, Inc. Company. 2011. Available at: www.americanregent.com. Accessed September 30, 2011"},{"key":"2021120903100651200_B19","first-page":"1","article-title":"Guidelines for the prevention of intravascular catheter-related infections.","volume":"51","author":"O\u2019Grady","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"2021120903100651200_B20"},{"issue":"1","key":"2021120903100651200_B21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.sempedsurg.2009.11.001","article-title":"Short bowel syndrome: epidemiology and etiology.","volume":"19","author":"Wales","year":"2010","journal-title":"Semin Pediatr Surg"},{"issue":"6","key":"2021120903100651200_B22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/jcm.27.6.1317-1319.1989","article-title":"Incidence of catheter-associated gram-negative bacteremia in children with short bowel syndrome.","volume":"27","author":"Piedra","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2021120903100651200_B23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archsurg.1992.01420010027004","article-title":"Catheter sepsis in short-bowel syndrome.","volume":"127","author":"Kurkchubasche","year":"1992","journal-title":"Arch Surg"},{"issue":"2","key":"2021120903100651200_B24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MPG.0b013e31805905f9","article-title":"Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure.","volume":"45","author":"Torres","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"2021120903100651200_B25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpedsurg.2009.10.014","article-title":"Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.","volume":"45","author":"Cowles","year":"2010","journal-title":"J Pediatr Surg"},{"key":"2021120903100651200_B26","volume-title":"Free to Choose: A Personal Statement","author":"Friedman","year":"1980","edition":"."},{"key":"2021120903100651200_B27","unstructured":"US Department of Health and Human Services, Food and Drug Administration. Drug shortages Web site. Available at: www.fda.gov\/drugs\/drugsafety\/drugshortages\/default.htm. Accessed September 30, 2011"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/5\/e1369\/1057970\/peds_2011-3894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/5\/e1369\/1057970\/peds_2011-3894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T12:10:16Z","timestamp":1639051816000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/130\/5\/e1369\/32520\/Drug-Shortage-Associated-Increase-in-Catheter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,11,1]]},"published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-3894","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}